REQUEST A DEMO
Total
USD $0.00
Search more companies

GUP Ur Farmaciya (Russia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: GUP Ur Farmaciya Profile Updated: August 18, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Russian Download a sample report

GUP Ur Farmaciya is an enterprise located in Russia, with the main office in Izhevsk. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. It was first established on November 01, 2002. In its most recent financial highlights, the company reported a net sales revenue drop of 2.04% in 2023. Its total assets grew by 17.53% over the same period. The net profit margin of GUP Ur Farmaciya increased by 0.14% in 2023.

Headquarters
Dzerzhinskogo, 3
Izhevsk; Udmurt Republic; Postal Code: 426039

Contact Details: Purchase the GUP Ur Farmaciya report to view the information.

Website: http://farmacia18.ru

Basic Information
Outstanding Shares:
Purchase the GUP Ur Farmaciya report to view the information.
Registered Capital:
Purchase the GUP Ur Farmaciya report to view the information.
Incorporation Date:
November 01, 2002
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Farm-Servis Tekhnicheskii Tsentr
20%
Proizvodstvenno-Kommercheskoe Aktsionernoe Obshchestvo Zakrytogo Tipa Mediko-Veterinarnyi Tsentr
10%
Company Performance
Financial values in the chart are available after GUP Ur Farmaciya report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
-2.04%
Total operating revenue
-2.04%
Operating profit (EBIT)
9.16%
Net Profit (Loss) for the Period
3.13%
Total assets
17.53%
Total equity
10.27%
Operating Profit Margin (ROS)
0.32%
Net Profit Margin
0.14%
Return on Equity (ROE)
-0.96%
Quick Ratio
0.25%
Cash Ratio
0.36%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?